Circulating Soluble P-selectin Must Dimerize to Promote Inflammation and Coagulation in Mice
Overview
Authors
Affiliations
Leukocyte adhesion to P-selectin on activated platelets and endothelial cells induces shedding of the P-selectin ectodomain into the circulation. Plasma soluble P-selectin (sP-selectin) is elevated threefold to fourfold in patients with cardiovascular disease. Circulating sP-selectin is thought to trigger signaling in leukocytes that directly contributes to inflammation and thrombosis. However, sP-selectin likely circulates as a monomer, and in vitro studies suggest that sP-selectin must dimerize to induce signaling in leukocytes. To address this discrepancy, we expressed the entire ectodomain of mouse P-selectin as a monomer (sP-selectin) or as a disulfide-linked dimer fused to the Fc portion of mouse immunoglobulin G (sP-selectin-Fc). Dimeric sP-selectin-Fc, but not monomeric sP-selectin, triggered integrin-dependent adhesion of mouse leukocytes in vitro. Antibody-induced oligomerization of sP-selectin or sP-selectin-Fc was required to trigger formation of neutrophil extracellular traps. Injecting sP-selectin-Fc, but not sP-selectin, into mice augmented integrin-dependent adhesion of neutrophils in venules, generated tissue factor-bearing microparticles, shortened plasma-clotting times, and increased thrombus frequency in the inferior vena cava. Furthermore, transgenic mice that overexpressed monomeric sP-selectin did not exhibit increased inflammation or thrombosis. We conclude that elevated plasma sP-selectin is a consequence rather than a cause of cardiovascular disease.
Inflammatory and Cardiovascular Responses to Active and Passive Acute Psychological Stress.
Linsley V, Bishop N, Roberts M, Hamrouni M, Demashkieh M, Paine N Biopsychosoc Sci Med. 2025; 87(2):107-117.
PMID: 39909009 PMC: 11801429. DOI: 10.1097/PSY.0000000000001367.
Sialyl Lewis Glycomimetics as E- and P-Selectin Antagonists Targeting Hyperinflammation.
Joyal M, Simard R, Maharsy W, Prevost M, Nemer M, Guindon Y ACS Med Chem Lett. 2025; 16(1):64-71.
PMID: 39811128 PMC: 11726361. DOI: 10.1021/acsmedchemlett.4c00452.
Wang K, Wang S, Margolis S, Cho J, Zhu E, Dupuy A Sci Adv. 2024; 10(50):eadq6778.
PMID: 39661669 PMC: 11633740. DOI: 10.1126/sciadv.adq6778.
Exploration on the effect of anserine on the alleviation of DVT and its molecular mechanism.
Li Y, Ge J, Yin Y, He J, Shang L Front Pharmacol. 2024; 15:1402758.
PMID: 38846090 PMC: 11154784. DOI: 10.3389/fphar.2024.1402758.
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.
Nilius H, Hamzeh-Cognasse H, Hastings J, Studt J, Tsakiris D, Greinacher A Blood Adv. 2024; 8(11):2825-2834.
PMID: 38588487 PMC: 11176969. DOI: 10.1182/bloodadvances.2024012782.